位置:首页 > 蛋白库 > CE295_HUMAN
CE295_HUMAN
ID   CE295_HUMAN             Reviewed;        2601 AA.
AC   Q9C0D2; C9J5H9; C9JQY8; Q8N7L4; Q8N919; Q8N9B0; Q96LT8;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 4.
DT   03-AUG-2022, entry version 127.
DE   RecName: Full=Centrosomal protein of 295 kDa {ECO:0000305};
GN   Name=CEP295 {ECO:0000312|HGNC:HGNC:29366};
GN   Synonyms=KIAA1731 {ECO:0000312|HGNC:HGNC:29366};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS GLN-208
RP   AND GLU-499.
RC   TISSUE=Brain;
RX   PubMed=11214970; DOI=10.1093/dnares/7.6.347;
RA   Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIX. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:347-355(2000).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-2566 (ISOFORM 4), AND NUCLEOTIDE SEQUENCE [LARGE
RP   SCALE MRNA] OF 2152-2601 (ISOFORM 3).
RC   TISSUE=Cerebellum, Chondrocyte, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   SUBCELLULAR LOCATION, AND POSSIBLE FUNCTION.
RX   PubMed=20844083; DOI=10.1091/mbc.e10-03-0246;
RA   Knorz V.J., Spalluto C., Lessard M., Purvis T.L., Adigun F.F., Collin G.B.,
RA   Hanley N.A., Wilson D.I., Hearn T.;
RT   "Centriolar association of ALMS1 and likely centrosomal functions of the
RT   ALMS motif-containing proteins C10orf90 and KIAA1731.";
RL   Mol. Biol. Cell 21:3617-3629(2010).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; SER-654; SER-938;
RP   SER-1637 AND THR-2473, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25131205; DOI=10.1016/j.celrep.2014.07.022;
RA   Izquierdo D., Wang W.J., Uryu K., Tsou M.F.;
RT   "Stabilization of cartwheel-less centrioles for duplication requires
RT   CEP295-mediated centriole-to-centrosome conversion.";
RL   Cell Rep. 8:957-965(2014).
RN   [8]
RP   FUNCTION, INTERACTION WITH MICROTUBULES, SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=27185865; DOI=10.1242/jcs.186338;
RA   Chang C.W., Hsu W.B., Tsai J.J., Tang C.J., Tang T.K.;
RT   "CEP295 interacts with microtubules and is required for centriole
RT   elongation.";
RL   J. Cell Sci. 129:2501-2513(2016).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=32060285; DOI=10.1038/s41467-020-14767-2;
RA   Atorino E.S., Hata S., Funaya C., Neuner A., Schiebel E.;
RT   "CEP44 ensures the formation of bona fide centriole wall, a requirement for
RT   the centriole-to-centrosome conversion.";
RL   Nat. Commun. 11:903-903(2020).
CC   -!- FUNCTION: Centriole-enriched microtubule-binding protein involved in
CC       centriole biogenesis (PubMed:20844083, PubMed:25131205,
CC       PubMed:27185865). Essential for the generation of the distal portion of
CC       new-born centrioles in a CENPJ- and CEP120-mediated elongation
CC       dependent manner during the cell cycle S/G2 phase after formation of
CC       the initiating cartwheel structure (PubMed:27185865). Required for the
CC       recruitment of centriolar proteins, such as POC1B, POC5 and CEP135,
CC       into the distal portion of centrioles (PubMed:27185865). Also required
CC       for centriole-to-centrosome conversion during mitotic progression, but
CC       is dispensable for cartwheel removal or centriole disengagement
CC       (PubMed:25131205). Binds to and stabilizes centriolar microtubule
CC       (PubMed:27185865). {ECO:0000269|PubMed:20844083,
CC       ECO:0000269|PubMed:25131205, ECO:0000269|PubMed:27185865,
CC       ECO:0000269|PubMed:32060285}.
CC   -!- SUBUNIT: Interacts (via ALMS motif) with microtubules; this interaction
CC       is direct. {ECO:0000269|PubMed:27185865}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome, centriole {ECO:0000269|PubMed:25131205,
CC       ECO:0000269|PubMed:27185865, ECO:0000269|PubMed:32060285}. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:20844083, ECO:0000269|PubMed:27185865}. Cytoplasm,
CC       cytoskeleton, spindle {ECO:0000269|PubMed:27185865}. Cytoplasm,
CC       cytoskeleton {ECO:0000269|PubMed:27185865}. Note=Associates with both
CC       of the converted centrioles during G1 but becomes more enriched at the
CC       newly formed daughter (or unconverted) centrioles during S, G2, and
CC       early M phases (PubMed:25131205, PubMed:32060285). In early S phase,
CC       localized at the procentriolar microtubule wall and enriched at the
CC       proximal ends of the centrioles in CENPJ- and CEP135-dependent manner
CC       (PubMed:27185865). Colocalizes with SASS6 and CEP250 proteins
CC       (PubMed:25131205). Colocalizes with CEP135 and CEP192 at the
CC       centrosomes (PubMed:27185865). Associates with interphase microtubules
CC       and mitotic spindles (PubMed:27185865). Colocalizes with centriolar
CC       acetylated tubulin (PubMed:25131205). {ECO:0000269|PubMed:25131205,
CC       ECO:0000269|PubMed:27185865, ECO:0000269|PubMed:32060285}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9C0D2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9C0D2-2; Sequence=VSP_032289, VSP_032290;
CC       Name=3;
CC         IsoId=Q9C0D2-3; Sequence=VSP_032291;
CC       Name=4;
CC         IsoId=Q9C0D2-4; Sequence=VSP_032288, VSP_032291;
CC   -!- DOMAIN: The N-terminal and the ALMS motif-containing C-terminal regions
CC       are essential for CEP295-mediated centriole elongation.
CC       {ECO:0000269|PubMed:27185865}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB21822.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB21822.2; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAB71582.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC04638.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB051518; BAB21822.2; ALT_SEQ; mRNA.
DR   EMBL; AK057804; BAB71582.1; ALT_INIT; mRNA.
DR   EMBL; AK095218; BAC04502.1; -; mRNA.
DR   EMBL; AK095859; BAC04638.1; ALT_INIT; mRNA.
DR   EMBL; AK098232; BAC05264.1; -; mRNA.
DR   EMBL; AP001273; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003499; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS44708.1; -. [Q9C0D2-1]
DR   RefSeq; NP_203753.1; NM_033395.1. [Q9C0D2-1]
DR   AlphaFoldDB; Q9C0D2; -.
DR   BioGRID; 124543; 65.
DR   IntAct; Q9C0D2; 27.
DR   STRING; 9606.ENSP00000316681; -.
DR   CarbonylDB; Q9C0D2; -.
DR   GlyGen; Q9C0D2; 2 sites, 2 O-linked glycans (2 sites).
DR   iPTMnet; Q9C0D2; -.
DR   PhosphoSitePlus; Q9C0D2; -.
DR   BioMuta; CEP295; -.
DR   DMDM; 296439480; -.
DR   EPD; Q9C0D2; -.
DR   jPOST; Q9C0D2; -.
DR   MassIVE; Q9C0D2; -.
DR   MaxQB; Q9C0D2; -.
DR   PaxDb; Q9C0D2; -.
DR   PeptideAtlas; Q9C0D2; -.
DR   PRIDE; Q9C0D2; -.
DR   ProteomicsDB; 80007; -. [Q9C0D2-1]
DR   ProteomicsDB; 80008; -. [Q9C0D2-2]
DR   ProteomicsDB; 80009; -. [Q9C0D2-3]
DR   ProteomicsDB; 80010; -. [Q9C0D2-4]
DR   Antibodypedia; 50774; 21 antibodies from 7 providers.
DR   Ensembl; ENST00000325212.11; ENSP00000316681.6; ENSG00000166004.15. [Q9C0D2-1]
DR   Ensembl; ENST00000531700.5; ENSP00000437323.1; ENSG00000166004.15. [Q9C0D2-2]
DR   GeneID; 85459; -.
DR   KEGG; hsa:85459; -.
DR   MANE-Select; ENST00000325212.11; ENSP00000316681.6; NM_033395.2; NP_203753.1.
DR   UCSC; uc001pdu.1; human. [Q9C0D2-1]
DR   CTD; 85459; -.
DR   GeneCards; CEP295; -.
DR   HGNC; HGNC:29366; CEP295.
DR   HPA; ENSG00000166004; Low tissue specificity.
DR   MIM; 617728; gene.
DR   neXtProt; NX_Q9C0D2; -.
DR   OpenTargets; ENSG00000166004; -.
DR   PharmGKB; PA142671597; -.
DR   VEuPathDB; HostDB:ENSG00000166004; -.
DR   eggNOG; ENOG502QSZR; Eukaryota.
DR   GeneTree; ENSGT00940000153123; -.
DR   HOGENOM; CLU_001093_0_0_1; -.
DR   InParanoid; Q9C0D2; -.
DR   OMA; FVNREMD; -.
DR   OrthoDB; 97863at2759; -.
DR   PhylomeDB; Q9C0D2; -.
DR   TreeFam; TF331536; -.
DR   PathwayCommons; Q9C0D2; -.
DR   SignaLink; Q9C0D2; -.
DR   BioGRID-ORCS; 85459; 80 hits in 1080 CRISPR screens.
DR   ChiTaRS; CEP295; human.
DR   GenomeRNAi; 85459; -.
DR   Pharos; Q9C0D2; Tbio.
DR   PRO; PR:Q9C0D2; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q9C0D2; protein.
DR   Bgee; ENSG00000166004; Expressed in oocyte and 184 other tissues.
DR   ExpressionAtlas; Q9C0D2; baseline and differential.
DR   Genevisible; Q9C0D2; HS.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:1990498; C:mitotic spindle microtubule; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0007099; P:centriole replication; IDA:UniProtKB.
DR   GO; GO:1903724; P:positive regulation of centriole elongation; IMP:UniProtKB.
DR   GO; GO:0010825; P:positive regulation of centrosome duplication; IDA:UniProtKB.
DR   GO; GO:1904951; P:positive regulation of establishment of protein localization; IMP:UniProtKB.
DR   GO; GO:1901985; P:positive regulation of protein acetylation; IMP:UniProtKB.
DR   GO; GO:0046599; P:regulation of centriole replication; IBA:GO_Central.
DR   InterPro; IPR029299; ALMS_motif.
DR   InterPro; IPR029560; CEP295.
DR   PANTHER; PTHR21553:SF25; PTHR21553:SF25; 1.
DR   Pfam; PF15309; ALMS_motif; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Cytoplasm; Cytoskeleton; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..2601
FT                   /note="Centrosomal protein of 295 kDa"
FT                   /id="PRO_0000324595"
FT   REGION          1..560
FT                   /note="Necessary for centriole targeting and microtubule
FT                   association"
FT                   /evidence="ECO:0000269|PubMed:27185865"
FT   REGION          1008..1029
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1558..1580
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1795..1834
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1979..2004
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2085..2117
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2478..2601
FT                   /note="ALMS motif"
FT   COILED          207..273
FT                   /evidence="ECO:0000255"
FT   COILED          500..552
FT                   /evidence="ECO:0000255"
FT   COILED          1053..1082
FT                   /evidence="ECO:0000255"
FT   COILED          1498..1544
FT                   /evidence="ECO:0000255"
FT   COILED          1728..1758
FT                   /evidence="ECO:0000255"
FT   COILED          2556..2581
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1558..1579
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1795..1831
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1983..2000
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2088..2117
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         654
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         938
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1637
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         2473
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..1988
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_032288"
FT   VAR_SEQ         1..1772
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_032289"
FT   VAR_SEQ         1818..1865
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_032290"
FT   VAR_SEQ         2466
FT                   /note="T -> TA (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_032291"
FT   VARIANT         80
FT                   /note="Q -> K (in dbSNP:rs7128850)"
FT                   /id="VAR_059337"
FT   VARIANT         208
FT                   /note="R -> Q (in dbSNP:rs10831088)"
FT                   /evidence="ECO:0000269|PubMed:11214970"
FT                   /id="VAR_059338"
FT   VARIANT         499
FT                   /note="A -> E (in dbSNP:rs4753495)"
FT                   /evidence="ECO:0000269|PubMed:11214970"
FT                   /id="VAR_059339"
FT   VARIANT         1026
FT                   /note="E -> K (in dbSNP:rs3802771)"
FT                   /id="VAR_059340"
FT   VARIANT         1270
FT                   /note="A -> G (in dbSNP:rs2298707)"
FT                   /id="VAR_059341"
FT   VARIANT         1441
FT                   /note="G -> E (in dbSNP:rs3802773)"
FT                   /id="VAR_059342"
FT   VARIANT         1459
FT                   /note="L -> R (in dbSNP:rs3802774)"
FT                   /id="VAR_059343"
FT   CONFLICT        511
FT                   /note="Q -> H (in Ref. 1; BAB21822)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1888
FT                   /note="F -> L (in Ref. 3; BAC04502)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2026
FT                   /note="V -> L (in Ref. 3; BAC05264)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2081
FT                   /note="P -> S (in Ref. 3; BAC05264)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2278
FT                   /note="S -> G (in Ref. 3; BAC05264)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2294
FT                   /note="Q -> R (in Ref. 3; BAC05264)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2437
FT                   /note="E -> V (in Ref. 3; BAB71582/BAC04502/BAC04638/
FT                   BAC05264)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2601 AA;  295176 MW;  F18F9B2EE1DAADC7 CRC64;
     MKRKVVNTHK LRLSPNEEAF ILKEDYERRR KLRLLQVREQ ERDIALQIRE DIKQRRNQQF
     TRLAEELRAE WEESQTQKIQ NLEKLYLASL RSMGEGHRQA KENEPDLDAL AQRAAERKRK
     ADLRHKEALK VQKNQKEILL KQKTWHIKAR KEALLVEKER SAKITSLPPP PPTLFENIEV
     KRISAVKTNS STYHHLHTFV NRETDTKRPD ARLAAEEEAK RLEELQKQAA QERMERFEKA
     HVRGFQAMKK IHLAQNQEKL MKELKQLQQE DLARRRQTVA QMPPQLVELP YKRSEMKEDW
     QRELEFAFED MYNADRKVKG NLILHLEPEP LPTVTNQIQD EELDLSMEQE NLGAAEDLPV
     TEAEICSSET DVPLVMKTQQ IPSKVLFKKL LNKIRSQKSL WTIKSMSEDE SEMITTVSEI
     ESKAPTVESG TIASKERTLS SGQEQVVESD TLTIESGPLA SEDKPLSCGT NSGKEQEINE
     TLPITTVAQS SVLLHPQEAA ARIRMSARQK QIMEIEEQKQ KQLELLEQIE QQKLRLETDC
     FRAQLEEEKR KKTQPTGVGI APASCPVISD EDSHRQMIRN YQHQLLQQNR LHRQSVETAR
     KQLLEYQTML KGRCPSVSAP SLITDSVISV PSWKSERPTA ISEHWDQGQR LKLSPNKYQP
     IQPIQTSKLE QDHFQVARQN HFPQRQVETT ETLRASDILT NQALESQEHL RQFSQTETQQ
     RDYKLVPKDS ETLSRALSHD RQLISQDARK ISETFGATTF QSLESQQLFS ENSENISYHL
     TEPSSFVPLV PQHSFSSLPV KVESGKIQEP FSAMSKSTVS TSHSIISQMH DRPLLPSENI
     TAQQGNMKAL QEQLDLQKKV LQATQEAQEQ LLLCKQKEVE QQTGLSVFLP LVTPDSSALL
     PSAKADLGRI QESSPTKNNI AVSSDHHVIS QLQDKRLSLS QPILSQQNNF KFLQEQLNIQ
     KDSLQARREA QEVLYVHKQS ELDRRVCSEQ AEPSFPFQVA QHTFTSLPSA DTKSGKIQEQ
     HSSKSEKGLV SCQSDIPISQ DGSLSFLQQF LPLHDSLKLL QEQLTKQRDT LQARHEAQVE
     LLLHRQRDLG DSKSGLVSSS SSPVVVQHSV ASQASAKAEP RRIQELYLSE KENVGPSCHL
     IIPTFQDKSL SFPQHSLAQQ ENLTILQEQS QIQRVILGAK EGTQEFVHTE SELEKRISSE
     QTGTSSSLSQ VDESERFQEC ISIKSDSTIP LSHPKIPRCQ ERLLRVSQHM LPLQDNLEEH
     QAWLDTEKEA FHFSQKTQEN TSSEQTGSSS FIPQLVQLSF TSLASAESGT ILEPLFTESE
     SKIFSSHLQI PQLQDRLLRI SQLIQPQQDN LKALQEQLAT QREAIILARQ EAREELLLHQ
     SEWEGRISPE QVDTSSLPLV PQHSFASLPL NESERNQEPC SINSDNIVSS GHSEIPTLPD
     GLLGLSHLVL PQQDNLIALE EHLHAQTDFL PSIEKTQKEL VLSKPCKFEE KVSSEHFIQS
     HHGDLQALQQ QLDTQKKAIR SIQEVQEELL LQRLSELEKR VSSEQVCSSS FVSQVPVADS
     ERTQKSFPTK SNDTLPSSHR EIPRLQDRLL SLSKPILPQQ DNMTAQLDAQ REVMYSYEKP
     QEELSLNKQR KLNKSESAEH TIPSLFLPKE TEHSFIPLPF AEAKPKSTCE LYSSQNEHAA
     PPSNPVIPGF QDRLLSFSQS VLTQQDNLGL QKQLDLQREV LHYSQKAQEK LLVQRQTALQ
     QQIQKHEETL KDFFKDSQIS KPTVENDLKT QKMGQLRDWF PNTQDLAGND QENIRHADRN
     NSDDNHLASE DTSAKQSGEH LEKDLGRRSS KPPVAKVKCG LDLNQHELSA IQEVESPAIG
     RTSILGKPGI YEDRDPLRVS ISREQSFFGS PLAHDPFSCL QLVGQENVCG DDYDEAVKLK
     ESVVENHAVL SYAVEEEHAY LGPTVKPDDK AKTLSYEPLS SATVSTGSLL SYENTDLSLT
     DPESFSEHMD DSKQESTTSK EEETNIISSI VPSTQDIYQR QNSSDVHKSL LPAVDETTCG
     HTHFQQMIDK YINEANLIPE KTDLQELEHI FPNLHHQLFK PLEPHPDFDL SSSSSGISPD
     NRDFYQRSDS SSESHCATGL SKSTVYFTAL RRTSMHSSLN TSPNQQPDTN LAHVGAHSFA
     TENIIGGSEQ CFEQLQPEYS SQEESQHADL PSIFSIEARD SSQGMKNQNY PSEEHTEILQ
     NKKKIVHFQL SIGNLSSVYS SSDEANVFDQ LNVQHSTPCG SNSSECSTKH QLESRKESMG
     FEELSKRGVV TMLQSQGLIE DNKNETCRVL DINPQVEETD SRLCVRTVEM GTSIQAPYSL
     TTQNEKYFEN SAETDIPKIT KKLSQLGESE LFASSGSFSL QSSIPVWETE TGHGIMEEPE
     LTLISTTDTS IAEMDFANLT LEEKSENEAK CFFQVSEFLP LVSATEASDY PAVSELSIEK
     PRTASTETPR RLTPVPGSLQ EAFIKRKKSF MERSHQRQKE IRNKIHVSEN SQIKTVKEKP
     SISSSVSRLK GVNKVRASFP EDRKTTQALR HQRGLRLYNQ LAEVKQQKEE KTKQEAYAQN
     RARAKEFHKK TLEKLRAKNT C
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024